RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 13 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > 2020 > 3 > COVID-19 vaccine tracker

COVID-19 vaccine tracker

Posted 04 June 2020 | By Jeff Craven 

COVID-19 vaccine tracker

Researchers worldwide are working around the clock to find a vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. Experts estimate that a fast-tracked vaccine development process could speed a successful candidate to market in approximately 12-18 months – if the process goes smoothly from conception to market availability.
 
This tracker lists COVID-19 vaccine candidates currently in Phase 1-3 trials, as well as major candidates in pre-clinical stages of development and research. Information will be updated weekly. If you notice an issue with this data or wish to submit an update, please email Focus at news@raps.org
 
Updated 4 June to include new information on Novavax's candidate and to correct errors associated with candidates from the University of Pittsburgh. We regret those errors. 

 

 

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe